August 8, 2025 · Form 4 insider transaction
Mazur Leonard L bought 125,490 shares of Citius Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 46 days after the transaction.
The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.